Bahrain will soon roll out the oral Covid-19 antiviral Paxlovid, confirmed a senior medic.
The country is awaiting the shipment of the medicine manufactured by Pfizer, which was approved for emergency use in Bahrain earlier this month, National Taskforce to Combat Covid-19 senior member Dr Jameela Al Salman said.
The National Health Regulatory Authority (NHRA) approved the pill after its pharmaceutical products regulation department evaluated data provided by Pfizer.
“After dealing with Covid-19 for two years, it’s important at this stage to use medications to battle the virus,” Dr Al Salman said.
“Paxlovid would limit the replication of the virus. It’s used for people with mild and moderate symptoms and has been proven effective.
“Initial results show that it reduces the risk of hospitalisation by 88 per cent, which is encouraging.”
The Salmaniya Medical Complex (SMC) infectious diseases consultant explained that patients can take the pills at home for five days.
Read More - www.gdnonline.com
